Cell Biotech Co., Ltd. (KOSDAQ:049960)
South Korea flag South Korea · Delayed Price · Currency is KRW
12,670
+30 (0.24%)
At close: May 13, 2025, 3:30 PM KST

Cell Biotech Revenue

In the year 2024, Cell Biotech had annual revenue of 49.91B KRW, down -7.20%. Cell Biotech had revenue of 12.16B in the quarter ending December 31, 2024, a decrease of -18.10%.

Revenue
49.91B
Revenue Growth
-7.20%
P/S Ratio
1.74
Revenue / Employee
449.66M
Employees
111
Market Cap
86.71B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202449.91B-3.87B-7.20%
Dec 31, 202353.79B3.26B6.46%
Dec 31, 202250.53B3.65B7.79%
Dec 31, 202146.87B1.29B2.83%
Dec 31, 202045.58B-377.42M-0.82%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Electronics 308.07T
SK hynix 71.40T
LG Energy Solution 25.76T
Samsung Biologics 4,547.32B
Hyundai Motor Company 178.98T
Hanwha Aerospace 11.24T
Kia Corporation 107.45T
HD Hyundai Heavy Industries 14.49T
Revenue Rankings